Advances in the study on strongyloidosis;Avances en el estudio sobre la estrongiloidosis

Enfermedades Emergentes

Volumn 7, Issue 2, 2005, Pages 102-109

  Ruano, Ana L ^a   Martín, Teresa ^a   Pardo, Javier ^a   López Abán, Julio ^a   Alvarez Muro, Antonio ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Review; Strongyloides stercoralis; Strongyloidosis

Indexed keywords

IVERMECTIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; FECES ANALYSIS; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE DEFICIENCY; MORTALITY; NONHUMAN; SERODIAGNOSIS; STRONGYLOIDES; STRONGYLOIDIASIS;

EID: 33846684901     PISSN: 15754723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Cox FEG. History of human Parasitology. Clin Microb Review 2002;15:595-612.
2. Globe DI. A History of Human Helminthology. CAB international, Wallingford, Reino Unido 1990:543-70.
3. Grove DI. Human Strongyloidiasis. Adv Parasitol 1996;38:251-309.
4. Little MD. Comparative morphology of six species of Strongyloides (Nematoda) and redefinition of the genus. J. Parasitology 1966;52:69-84.
5. Hammond M, Robinson R. Endoreplication in the ovary, testis, and intestine of Strongyloides stercoralis. J Parasitol 1994;80:905-10.
6. Pereira ND, Melo AL, Genaro O. Strongyloides stercoralis. En: Parasitología Humana; Editorial Atheneu 10ma edición. Sao Paulo. 2000:247-56.
7. Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 2001;33:1040-47.
8. Jorgensen T, Montresor A, Savioli L. Effectively controlling strongyloidiasis. Parasitol Today 1996;12:164.
9. Pires ML, Dreyer G. The importance of Strongyloides stercoralis revisited. Rev Hosp Clin Fac Med Sao Paulo. 1993;48:175-82.
10. Panaitescu D, Capraru T, Bugarin V. Study of the incidence of intestinal and systemic parasitoses in a group of children with handicaps. Roum Arch Microbiol Immunol 1995;54:65-74.
11. Genta RM, Gatti S, Linke MJ, Cevini C, Scaglia M. Endemic strongyloidiasis in northern Italy: clinical and immunological aspects. Q J Med 1988;68:679-90.
12. Magnaval JF, Mansuy JM, Villeneuve L, Cassaing S. A retrospective study of autochthonous strongyloidiasis in Region Midi-Pyrenees (Southwestern France). Eur J Epidemiol 2000;16:179-82.
13. Junod C. Retrospective study of 1,934 cases of strongyloidiasis diagnosed in Paris (1970-1986). I. Geographic origin. Epidemiology. Bull Soc Pathol Exot Filiales 1987;80:357-69
14. Segovia Hernandez M, Martínez Toldos C. Clinical significance of Strongyloides stercoralis in our environment. Rev Clin Esp 2001;201:57-8.
15. Sánchez PR, Guzmán AP, Guillén SM, Adell RI, Estruch AM, Gonzalo IN, Olmos. CR. Endemic strongyloidiasis on the Spanish Mediterranean coast. QJM 2001;94: 357-63.
16. McKerrow JH, Brindley P, Brown M, Gam AA, Staunton C, Neva FA. Strongyloides stercoralis: identification of a protease that facilitates penetration of skin by the infective larvae. Exp Parasitol 1990;70:134-43.
17. Espinoza E, Pérez Arellano JL, Vicente B, Muro A. Cytoplasmic signalling pathways in alveolar macrophages involved in the production of nitric oxide after stimulation with excretory/secretory antigens of Toxocara canis. Parasite Immunol 2002;24:535-44.
18. Espinoza E, Muro A, Sánchez Martín MM, Casanueva P, Pérez Arellano JL. Toxocara canis antigens stimulate the production of nitric oxide and prostaglandin E2 by rat alveolar macrophages. Parasite Immunol 2002;24: 311-19.
19. Schad GA, Aikens LM, Smith G. Strongyloides stercoralis: is there a canonical migratory route through the host? J Parasitol 1989;75:740-9.
20. Onah DN, Uchiyama F, Nagakui Y, Ono M, Takai T, Nawa Y. Mucosal defense against gastrointestinal nematodes: responses of mucosal mast cells and mouse mast cell protease 1 during primary Strongyloides venezuelensis infection in FcRgamma-knockout mice. Infect Immun 2000;68:4968-71.
21. Maruyama H, Nawa Y, Ohta N. Strongyloides venezuelensis: binding of orally secreted adhesion substances to sulfated carbohydrates. Exp Parasitol 1998;89:16-20.
22. Maruyama H, Yabu Y, Yoshida A, Nawa Y, Ohta N. A role of mast cell glycosaminoglycans for the immunological expulsion of intestinal nematode, Strongyloides venezuelensis. J Immunol 2000;164:3749-54.
23. Kerepesi LA, Nolan TJ, Schad GA, et al. Human immunoglobulin G mediates protective immunity and identifies protective antigens against larval Strongyloides stercoralis in mice. J Infect Dis 2004;189:1282-90.
24. Herbert DR, Lee JJ, Lee NA, Nolan TJ, Schad GA, Abraham D. Role of IL-5 in innate and adaptive immunity to larval Strongyloides stercoralis in mice. J Immunol 2000;165:4544-51.
25. Porto AF, Neva FA, Bittencourt H, et al. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. Parasite Immunol 2001;23:503-07.
26. Adedayo AO, Grell GA, Bellot P. Case study: fatal strongyloidiasis associated with human T-cell lymphotropic virus type 1 infection. Am J Trop Med Hyg 2001;65:650-51.
27. De Messias IJ, Genta RM, Mohren WD. Adherence of monocytrs and polymorphonuclear cells to infective larvae of Strongyloides stercoralis after complement activation. J Parasitol 1994;80:267-74
28. Román Sánchez P. Endemic strongyloidiasis on the Spanish Mediterranean coast. Q J Med 2001;94:357-63.
29. Lindo JF, Atkins NS, Lee MG, Robinson RD, Bundy DAP. Short report: Long-term serum antibody isotipe responses to Strongyloides stercoralis filariform antigens in eight patients treated with ivermectin. Am J Trop Med Hyg 1996;55:474-6.
30. Ly MN, Bethel SL, Usmani AS, Lambert DR. Cutaneous Strongyloides stercoralis infection: an unusual presentation. J Am Acad Dermatol 2003;49:S157-60.
31. Silveira MR, Nunes KP, Cara DC, Souza DG, Correa A Jr, Teixeira MM, Negrao-Correa D. Infection with Strongyloides venezuelensis induces transient airway eosinophilic inflammation, an increase in immunoglobulin E, and hyperresponsiveness in rats. Infect Immun 2002;70:6263-72.
32. Cremades Romero MJ, Pellicer Ciscar C, Menéndez Villanueva R, Ricart Olmos C, Pastor-Guzmán A, Estelles Piera F, Igual Adell R, Gilabert Bonet MJ. Strongyloides stercoralis infection in patients with bronchial obstructive pathology. Arch Bronconeumol 1997;33:384-8.
33. Wehner JH, Kirsch CM, Kagawa FT, Jensen WA, Campagna AC, Wilson M. The prevalence and response to therapy of Strongyloides stercoralis in patients with asthma from endemic areas. Chest 1994;106:762-6.
34. Keiser PB, Nutman TB. Strongyloides stercolaris in the immunocompromised population. Clin Microbiol Rev 2004;17:208-17
35. Gill GV, Beeching NJ, Khoo S, Bailey JW, Partridge S, Blundell JW, Luksza AR. A British Second World War veteran with disseminated strongyloidiasis. Trans R Soc Trop Med Hyg 2004;98:382-6.
36. Muro A, Ramajo V, Pérez Arellano JL. Helmintosis en el individuo inmunocompetente III nematodosis En: Pérez Arellano JL, et al. Guía de Autoformación en Enfermedades Infecciosas. Madrid: Editorial Panamericana, 1996:1109-27.
37. Lemos LB, Qu Z, Laucirica R, Fred HL. Hyperinfection syndrome in strongyloidiasis: Report of two cases. Ann Diagn Pathol 2003;7:87-94.
38. Karp CI, Neva FA. Tropical infectious diseases in human immunodeficiency virus-infected patients. Clin Infec Dis 1999;28:947-65.
39. Palau LA, Pankey GA. Strongyloides hyperinfection in renal transplant recipient receiving cyclosporine: possible Strongyloides stercoralis transmission by kidney transplant. Am J Trop Med Hyg 1997;57:413 5.
40. Safdar A, Malathum K, Rodriguez SJ, Husni R, Rolston KV. Strongyloidiasis in patients at a comprehensive cancer center in the United States. Cancer 2004;100:1531-6.
41. Pardo G, Rodriguez R, Campillos MT. Strongyloides stercoralis: Factores de riesgo para estrongiloidosis diseminada. Med Clin (Barc) 2003;121:662-4.
42. Vighi G, Schroeder J, Gallo C, Ortolani C. Enterotest and Strongyloides stercoralis. Lancet 1989;15;2: 156-7.
43. Lynne LS. Practical Guide to Diagnostic Parasitology. Washinton DC: American Society of Microbiology, 1999:46-50.
44. Siddiqui AA, Koenig NM, Sinensky M, Berk SL. S. stercoralis: Identification of antigens in natural human infections from endemic areas of the United States. Parasitol Res 1997;83:655-58.
45. Arakaki T, Iwanaga M, Kinjo F, Saito A, Asato R and Ikeshiro T. Efficacy of agar-plate culture in detection of Strongyloides stercoralis infection. J Parasitol 1990;76:425-28.
46. Nageswaran C, Craig PS, Devaney E. Coproantigen detection in rats experimentally infected with Strongyloides ratti. Parasitology 1994;108:335-42.
47. Neva FA, Gam AA, Maxwell C, Pelletier LL. Skin test antigens for immediate hypersensitivity prepared from infective larvae of Strongyloides stercoralis. Am J Trop Med Hyg 2001;65:567-72.
48. Gam AA, Neva FA, Krotoski WA. Comparative sensitivity and specificity of ELISA and IHA for serodiagnosis of strongyloidiasis with larval antigens. Am J Trop Med Hyg 1987;37:157-61.
49. Machado ER, Ueta MT, de Fatima Goncalves-Pires Mdo R, Alves de Oliveira JB, Faccioli LH, Costa-Cruz JM Strongyloides venezuelensis alkaline extract for the diagnosis of human strongyloidiasis by enzyme-linked immunosorbent assay. Mem Inst Oswaldo Cruz 2003; 98:849-51.
50. Dekumyoy P, Somtana K, Jantanawiwat P, Nuamtanong S, Sa-nguankiat S, Nuchfaong S, Janyapoon K, Chindanond D. Improved antigens for IgG-ELISA diagnosis of strongyloidiasis. Southeast Asian J Trop Med Public Health 2002;3:53-9.
51. Silva LP, Barcelos IS, Passos-Lima AB, Espindola FS, Campos DM, Costa-Cruz JM. Western blotting using Strongyloides ratti antigen for the detection of IgG antibodies as confirmatory test in human strongyloidiasis. Mem Inst Oswaldo Cruz 2003;98:687-91.
52. Aparicio P, Rodrigues E, Gárate T, Molina R, Soto A, Alvar J. Terapéutica antiparasitaria. Enfer Infecc Microbiol Clin 2003;2:579-94.
53. Gann PH, Neva FA, Gam AA. A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J Infect Dis 1994; 169:1076-79.
54. Tarr PE, Miele PS, Peregoy KS, Smith MA, Neva FA, Lucey DR. Case report: Rectal adminstration of ivermectin to a patient with Strongyloides hyperinfection syndrome. Am J Trop Med Hyg 2003;68: 453-5.
55. Conder GA, Williams JF. Immunization with infective larvae of Strongyloides ratti (Nematoda) exposed to microwave radiation. J Parasitol 1983;69:83-87
56. Abraham D, Rotman HL, Haberstroh HF, et al. Strongyloides stercoralis: protective immunity to third-stage larvae in BALB/c ByJ mice. Exp Parasitol 1995; 80:297307.
57. Rotman HL, Schnyder-Candrian S, Scott P, Nolan TJ, Schad GA, Abraham D. IL-12 eliminates the Th-2 dependent protective immune response of mice to larval Strongyloides stercoralis. Parasite Immunol 1997;19: 29-39.
58. Rotman HL, Yutanawiboonchai W, Brigandi RA, et al. Strongyloides stercoralis: eosinophil-dependent immune-mediated killing of third-stage larvae in BALB/ cByJ mice. Exp Parasitol 1996;82:267-78.